UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4394) 4394
Book Chapter (6) 6
Publication (4) 4
Newsletter (3) 3
Magazine Article (2) 2
Newspaper Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3996) 3996
epirubicin - administration & dosage (3419) 3419
female (3346) 3346
science & technology (2922) 2922
life sciences & biomedicine (2843) 2843
middle aged (2838) 2838
antineoplastic combined chemotherapy protocols - therapeutic use (2469) 2469
aged (2304) 2304
adult (2292) 2292
oncology (2129) 2129
male (1719) 1719
biological and medical sciences (1558) 1558
medical sciences (1556) 1556
chemotherapy (1550) 1550
breast neoplasms - drug therapy (1540) 1540
epirubicin (1279) 1279
cyclophosphamide - administration & dosage (1246) 1246
fluorouracil - administration & dosage (1223) 1223
treatment outcome (1059) 1059
pharmacology. drug treatments (1020) 1020
antineoplastic combined chemotherapy protocols - adverse effects (989) 989
antineoplastic agents (946) 946
breast cancer (882) 882
antineoplastic combined chemotherapy protocols - administration & dosage (842) 842
breast neoplasms - pathology (836) 836
epirubicin - adverse effects (835) 835
cisplatin - administration & dosage (814) 814
tumors (737) 737
cancer (724) 724
drug administration schedule (673) 673
chemotherapy, adjuvant (664) 664
neoplasm staging (616) 616
doxorubicin - administration & dosage (582) 582
disease-free survival (560) 560
combined modality therapy (546) 546
survival rate (544) 544
antibiotics, antineoplastic - administration & dosage (543) 543
anthracyclines (502) 502
prognosis (496) 496
epirubicin - therapeutic use (482) 482
paclitaxel - administration & dosage (468) 468
follow-up studies (447) 447
survival analysis (422) 422
prospective studies (382) 382
taxoids - administration & dosage (371) 371
neoadjuvant therapy (362) 362
retrospective studies (362) 362
dose-response relationship, drug (356) 356
medicine & public health (355) 355
pharmacology & pharmacy (353) 353
aged, 80 and over (351) 351
gynecology. andrology. obstetrics (350) 350
breast neoplasms - surgery (349) 349
care and treatment (315) 315
mammary gland diseases (315) 315
methotrexate - administration & dosage (307) 307
animals (292) 292
adenocarcinoma - drug therapy (286) 286
breast neoplasms - mortality (286) 286
cyclophosphamide (279) 279
stomach neoplasms - drug therapy (276) 276
cyclophosphamide - adverse effects (275) 275
etoposide - administration & dosage (274) 274
time factors (264) 264
vincristine - administration & dosage (258) 258
neoplasm metastasis (250) 250
surgery (247) 247
deoxycytidine - analogs & derivatives (245) 245
adolescent (244) 244
research (238) 238
fluorouracil - adverse effects (237) 237
deoxycytidine - administration & dosage (229) 229
remission induction (229) 229
lymphatic metastasis (224) 224
liver neoplasms - therapy (223) 223
liver neoplasms - drug therapy (221) 221
carboplatin - administration & dosage (220) 220
analysis (216) 216
antineoplastic agents - administration & dosage (215) 215
lung neoplasms - drug therapy (213) 213
mitomycin - administration & dosage (213) 213
docetaxel (209) 209
infusions, intra-arterial (206) 206
drug therapy (204) 204
urinary bladder neoplasms - drug therapy (204) 204
paclitaxel (202) 202
ifosfamide - administration & dosage (199) 199
cisplatin (196) 196
adjuvant treatment (194) 194
antibiotics, antineoplastic - adverse effects (193) 193
infusions, intravenous (193) 193
risk factors (188) 188
hematology (184) 184
abridged index medicus (183) 183
epirubicin - pharmacology (180) 180
carcinoma, hepatocellular - therapy (179) 179
health aspects (179) 179
vinblastine - administration & dosage (179) 179
neoadjuvant chemotherapy (178) 178
stomach neoplasms - pathology (176) 176
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4011) 4011
Japanese (325) 325
Chinese (88) 88
German (64) 64
French (46) 46
Italian (39) 39
Russian (19) 19
Spanish (18) 18
Polish (12) 12
Hungarian (9) 9
Portuguese (4) 4
Bulgarian (3) 3
Serbian (3) 3
Danish (2) 2
Korean (2) 2
Romanian (2) 2
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 11, pp. 1175 - 1181
Journal Article
The Lancet (British edition), ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1948 - 1957
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Oxaliplatin - therapeutic use | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Docetaxel - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Oxaliplatin - administration & dosage | Administration, Oral | Esophagogastric Junction - pathology | Treatment Outcome | Capecitabine - therapeutic use | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Digestive System Surgical Procedures | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Docetaxel - therapeutic use | Aged | Neoplasm Staging | Adenocarcinoma | Anthracyclines | Chemotherapy | Leucovorin | Product development | Esophageal cancer | Cancer | Intravenous administration | Control methods | Toxicity | Clinical trials | Oncology | Metastasis | Cancer therapies | Stomach cancer | Evidence-based medicine | Metastases | Confidence intervals | Infusion | Oxaliplatin | Surgery | Intravenous infusion | Epirubicin | Medical research | Survival | Patients | Cisplatin | Esophagus | Interactive systems | Medical prognosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Journal Article
British journal of haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 534 - 544
refractory disease | relapse | children | survival | Hodgkin lymphoma | Relapse | Children | Refractory disease | Survival | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Procarbazine - administration & dosage | Prednisolone - adverse effects | Recurrence | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Hodgkin Disease - surgery | Hodgkin Disease - mortality | Vincristine - administration & dosage | Child | Dacarbazine - administration & dosage | Dexamethasone - administration & dosage | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Bleomycin - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Ifosfamide - administration & dosage | Adolescent | Vincristine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Multicenter Studies as Topic | Hodgkin Disease - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Chlorambucil - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Clinical Trials as Topic | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Carmustine - administration & dosage | Patient outcomes | Diseases | Index Medicus
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 02/2019, Volume 2019, Issue 2, pp. CD012873 - CD012873
Anthracyclines | Nervous System | Neoadjuvant | Breast Neoplasms | Doxorubicin | Taxoids | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Chemotherapy, Adjuvant | Epirubicin | Fluorouracil | Neutropenia | Drug Administration Schedule | Docetaxel | Antineoplastic Agents | Antibiotics, Antineoplastic | Randomized Controlled Trials as Topic | Cyclophosphamide | Chemotherapy | Quality of Life | Breast | Disease‐Free Survival | Medicine General & Introductory Medical Sciences | Early breast cancer | Cancer | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anthracyclines - adverse effects | Cyclophosphamide - administration & dosage | Docetaxel - adverse effects | Humans | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Agents - administration & dosage | Epirubicin - administration & dosage | Cyclophosphamide - adverse effects | Docetaxel - administration & dosage | Anthracyclines - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Female | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Taxoids - adverse effects | Doxorubicin - administration & dosage | Paclitaxel - adverse effects | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Nervous System - drug effects | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Doxorubicin - adverse effects | Epirubicin - adverse effects | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 10/2015, Volume 121, Issue 20, pp. 3639 - 3648
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2020, Volume 382, Issue 9, pp. 810 - 821
Journal Article